Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Letter to the Editor: "Decreased Serum 25-Hydroxyvitamin D in Aging Male Mice Is Associated With Reduced Hepatic Cyp2r1 Abundance".

Wion D.

Endocrinology. 2018 Oct 1;159(10):3563-3564. doi: 10.1210/en.2018-00692. No abstract available.

PMID:
30192936
2.

The Temporal Relationship Between Alzheimer's Disease and Depressive Symptoms: Variable Matters.

Wion D.

Am J Psychiatry. 2018 Aug 1;175(8):793. doi: 10.1176/appi.ajp.2018.18020164. No abstract available.

PMID:
30064250
3.

Inflammation and Inflammatory Diseases: How Our Language Influences Our Therapeutic Paradigms.

Chabrol T, Berger F, Wion D.

Bioessays. 2018 Sep;40(9):e1800103. doi: 10.1002/bies.201800103. Epub 2018 Jul 10. No abstract available.

PMID:
29989182
4.

Biomarkers of aging associated with past treatments in breast cancer survivors: when therapy-induced pathways turn out to be potential therapeutic targets.

Jabbour W, Wion D.

NPJ Breast Cancer. 2018 Mar 6;4:4. doi: 10.1038/s41523-018-0058-6. eCollection 2018. No abstract available.

5.

Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma.

Séhédic D, Chourpa I, Tétaud C, Griveau A, Loussouarn C, Avril S, Legendre C, Lepareur N, Wion D, Hindré F, Davodeau F, Garcion E.

Theranostics. 2017 Oct 12;7(18):4517-4536. doi: 10.7150/thno.19403. eCollection 2017.

6.

Vitamin D and mental health: optimizing in the midst of the complexity.

Landel V, Wion D.

Acta Psychiatr Scand. 2017 Aug;136(2):228-229. doi: 10.1111/acps.12760. Epub 2017 May 29. No abstract available.

PMID:
28556900
7.

Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia.

Wion D.

J Neurooncol. 2017 Jul;133(3):447-454. doi: 10.1007/s11060-017-2471-3. Epub 2017 May 17. Review.

PMID:
28516343
8.

Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.

Kast RE, Hill QA, Wion D, Mellstedt H, Focosi D, Karpel-Massler G, Heiland T, Halatsch ME.

Tumour Biol. 2017 May;39(5):1010428317699797. doi: 10.1177/1010428317699797. Review.

PMID:
28459367
9.

Glioma resection and tumor recurrence: back to Semmelweis.

Ratel D, van der Sanden B, Wion D.

Neuro Oncol. 2016 Dec;18(12):1688-1689. Epub 2016 Oct 7. No abstract available.

10.

Extent of Resection and Survival in Glioblastoma Multiforme.

Jabbour W, Wion D.

JAMA Oncol. 2016 Nov 1;2(11):1509. doi: 10.1001/jamaoncol.2016.3809. No abstract available.

PMID:
27684359
11.

Design of Hyaluronic Acid Hydrogels to Promote Neurite Outgrowth in Three Dimensions.

Tarus D, Hamard L, Caraguel F, Wion D, Szarpak-Jankowska A, van der Sanden B, Auzély-Velty R.

ACS Appl Mater Interfaces. 2016 Sep 28;8(38):25051-9. doi: 10.1021/acsami.6b06446. Epub 2016 Sep 16.

PMID:
27598554
12.

Glioma Recurrence following Surgery: Peritumoral or Perilesional?

van der Sanden B, Ratel D, Berger F, Wion D.

Front Neurol. 2016 Mar 31;7:52. doi: 10.3389/fneur.2016.00052. eCollection 2016. Review. No abstract available.

13.

The brain tissue response to surgical injury and its possible contribution to glioma recurrence.

Hamard L, Ratel D, Selek L, Berger F, van der Sanden B, Wion D.

J Neurooncol. 2016 May;128(1):1-8. doi: 10.1007/s11060-016-2096-y. Epub 2016 Mar 9. Review.

PMID:
26961772
14.

RE: Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.

Wion-Barbot N, Wion D.

J Natl Cancer Inst. 2015 Nov 7;108(1). pii: djv320. doi: 10.1093/jnci/djv320. Print 2016 Jan. No abstract available.

15.

Cancer research in need of a scientific revolution: Using 'paradigm shift' as a method of investigation.

Wion D, Appaix F, Burruss M, Berger F, van der Sanden B.

J Biosci. 2015 Sep;40(3):657-66. Review.

16.

Investigating the relationship between vitamin D and cancer requires dosing the bioavailable nonhydroxylated vitamin D storage in cancer tissues.

Dreyfus M, Wion D.

Cancer. 2015 Sep 15;121(18):3362-3. doi: 10.1002/cncr.29451. Epub 2015 May 19. No abstract available.

17.

Expression of CYP2R1 and VDR in human brain pericytes: the neurovascular vitamin D autocrine/paracrine model.

El-Atifi M, Dreyfus M, Berger F, Wion D.

Neuroreport. 2015 Mar 25;26(5):245-8. doi: 10.1097/WNR.0000000000000328.

PMID:
25730676
18.

Additional clues for a protective role of vitamin D in neurodegenerative diseases: 1,25-dihydroxyvitamin D3 triggers an anti-inflammatory response in brain pericytes.

Nissou MF, Guttin A, Zenga C, Berger F, Issartel JP, Wion D.

J Alzheimers Dis. 2014;42(3):789-99. doi: 10.3233/JAD-140411.

PMID:
24934545
19.

Generation of brain cancer stem cells: the dark side of brain pericytes?

Nugue G, Wion D.

Neurosci Res. 2014 Aug;85:69. doi: 10.1016/j.neures.2014.05.004. Epub 2014 May 27. No abstract available.

PMID:
24874004
20.

Brain mesenchymal stem cells: The other stem cells of the brain?

Appaix F, Nissou MF, van der Sanden B, Dreyfus M, Berger F, Issartel JP, Wion D.

World J Stem Cells. 2014 Apr 26;6(2):134-43. doi: 10.4252/wjsc.v6.i2.134. Review.

21.

Imaging and histological characterization of a human brain xenograft in pig: the first induced glioma model in a large animal.

Selek L, Seigneuret E, Nugue G, Wion D, Nissou MF, Salon C, Seurin MJ, Carozzo C, Ponce F, Roger T, Berger F.

J Neurosci Methods. 2014 Jan 15;221:159-65. doi: 10.1016/j.jneumeth.2013.10.002. Epub 2013 Oct 11.

PMID:
24126047
22.

Synergistic effect of cisplatin and synchrotron irradiation on F98 gliomas growing in nude mice.

Ricard C, Fernandez M, Requardt H, Wion D, Vial JC, Segebarth C, van der Sanden B.

J Synchrotron Radiat. 2013 Sep;20(Pt 5):777-84. doi: 10.1107/S0909049513016567. Epub 2013 Jul 3.

23.

Translation of the ecological trap concept to glioma therapy: the cancer cell trap concept.

van der Sanden B, Appaix F, Berger F, Selek L, Issartel JP, Wion D.

Future Oncol. 2013 Jun;9(6):817-24. doi: 10.2217/fon.13.30.

24.

Hypoxia-induced expression of VE-cadherin and filamin B in glioma cell cultures and pseudopalisade structures.

Nissou MF, El Atifi M, Guttin A, Godfraind C, Salon C, Garcion E, van der Sanden B, Issartel JP, Berger F, Wion D.

J Neurooncol. 2013 Jun;113(2):239-49. doi: 10.1007/s11060-013-1124-4. Epub 2013 Mar 31.

25.

The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.

Nissou MF, Brocard J, El Atifi M, Guttin A, Andrieux A, Berger F, Issartel JP, Wion D.

J Alzheimers Dis. 2013;35(3):553-64. doi: 10.3233/JAD-122005.

26.

Angiogenesis and the tumor space-time continuum.

Nugue G, Wion D.

Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):E914; author reply E915. doi: 10.1073/pnas.1203154109. Epub 2012 Mar 26. No abstract available.

27.

Cortical dysplasia: a possible substrate for brain tumors.

Liu S, Zhang C, Shu H, Wion D, Yang H.

Future Oncol. 2012 Mar;8(3):251-8. doi: 10.2217/fon.12.6.

28.

Biodiversity as a barrier to glioma cell invasion.

Selek L, Mauconduit F, Nissou MF, Nugue G, Lahrech H, Berger F, Mossuz P, Wion D.

Med Hypotheses. 2012 Apr;78(4):459-61. doi: 10.1016/j.mehy.2012.01.005. Epub 2012 Feb 1.

29.

In vitro expansion of human glioblastoma cells at non-physiological oxygen tension irreversibly alters subsequent in vivo aggressiveness and AC133 expression.

Bourseau-Guilmain E, Lemaire L, Griveau A, Hervouet E, Vallette F, Berger F, Menei P, Benoit JP, Wion D, Garcion E.

Int J Oncol. 2012 Apr;40(4):1220-9. doi: 10.3892/ijo.2011.1271. Epub 2011 Nov 23.

30.

MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes.

Lages E, Guttin A, El Atifi M, Ramus C, Ipas H, Dupré I, Rolland D, Salon C, Godfraind C, deFraipont F, Dhobb M, Pelletier L, Wion D, Gay E, Berger F, Issartel JP.

PLoS One. 2011;6(5):e20600. doi: 10.1371/journal.pone.0020600. Epub 2011 May 31.

31.

The heterogeneity of meningioma revealed by multiparameter analysis: infiltrative and non-infiltrative clinical phenotypes.

Gay E, Lages E, Ramus C, Guttin A, El Atifi M, Dupré I, Bouamrani A, Salon C, Ratel D, Wion D, Berger F, Issartel JP.

Int J Oncol. 2011 May;38(5):1287-97. doi: 10.3892/ijo.2011.944. Epub 2011 Feb 11.

PMID:
21318223
32.

Optimizing stem cell culture.

van der Sanden B, Dhobb M, Berger F, Wion D.

J Cell Biochem. 2010 Nov 1;111(4):801-7. doi: 10.1002/jcb.22847.

33.

Existence of tumor-derived endothelial cells suggests an additional role for endothelial-to-mesenchymal transition in tumor progression.

Selek L, Dhobb M, van der Sanden B, Berger F, Wion D.

Int J Cancer. 2011 Mar 15;128(6):1502-3. doi: 10.1002/ijc.25446. No abstract available.

34.

Increased phosphorylation of vimentin in noninfiltrative meningiomas.

Bouamrani A, Ramus C, Gay E, Pelletier L, Cubizolles M, Brugière S, Wion D, Berger F, Issartel JP.

PLoS One. 2010 Feb 16;5(2):e9238. doi: 10.1371/journal.pone.0009238.

35.

PO(2) matters in stem cell culture.

Wion D, Christen T, Barbier EL, Coles JA.

Cell Stem Cell. 2009 Sep 4;5(3):242-3. doi: 10.1016/j.stem.2009.08.009. No abstract available.

36.

Characterisation of normal and cancer stem cells: one experimental paradigm for two kinds of stem cells.

Mayol JF, Loeuillet C, Hérodin F, Wion D.

Bioessays. 2009 Sep;31(9):993-1001. doi: 10.1002/bies.200900041.

37.

[Oxygen tension and cancer-cell culture: half a century of artifacts?].

Wion D, Dematteis M, Nissou MF, Cretallaz C, Berger F, Issartel JP.

Med Sci (Paris). 2008 Dec;24(12):1093-5. doi: 10.1051/medsci/200824121093. Review. French. No abstract available.

38.

Cancer stem cells: beyond Koch's postulates.

Garcion E, Naveilhan P, Berger F, Wion D.

Cancer Lett. 2009 Jun 8;278(1):3-8. doi: 10.1016/j.canlet.2008.09.006. Epub 2008 Oct 14. Review.

39.

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

Platet N, Liu SY, Atifi ME, Oliver L, Vallette FM, Berger F, Wion D.

Cancer Lett. 2007 Dec 18;258(2):286-90. Epub 2007 Oct 30.

40.

Effects of Hoechst 33342 on C2C12 and PC12 cell differentiation.

Adamski D, Mayol JF, Platet N, Berger F, Hérodin F, Wion D.

FEBS Lett. 2007 Jun 26;581(16):3076-80. Epub 2007 Jun 4.

41.

Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line.

Platet N, Mayol JF, Berger F, Hérodin F, Wion D.

FEBS Lett. 2007 Apr 3;581(7):1435-40. Epub 2007 Mar 7.

42.

Cancer stem cells.

Wion D, Berger F.

N Engl J Med. 2006 Dec 21;355(25):2703; author reply 2703. No abstract available.

PMID:
17183003
43.

Glioma, melatonin, and radiotherapy.

Wion D, Berger F, Wion-Barbot N.

Cancer Res. 2006 Jun 15;66(12):6457. No abstract available.

44.

Undetectable levels of N6-methyl adenine in mouse DNA: Cloning and analysis of PRED28, a gene coding for a putative mammalian DNA adenine methyltransferase.

Ratel D, Ravanat JL, Charles MP, Platet N, Breuillaud L, Lunardi J, Berger F, Wion D.

FEBS Lett. 2006 May 29;580(13):3179-84. Epub 2006 May 3.

45.

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome.

Bachelot T, Ratel D, Menetrier-Caux C, Wion D, Blay JY, Berger F.

Br J Cancer. 2006 Apr 10;94(7):1066-70.

46.

N6-methyl-adenine: an epigenetic signal for DNA-protein interactions.

Wion D, Casadesús J.

Nat Rev Microbiol. 2006 Mar;4(3):183-92. Review.

47.

N6-methyladenine: the other methylated base of DNA.

Ratel D, Ravanat JL, Berger F, Wion D.

Bioessays. 2006 Mar;28(3):309-15. Review.

48.

Should we control the pineal status of patients following brain radiotherapy?

Wion-Barbot N, Berger F, Wion D.

J Neurooncol. 2005 Sep;74(3):335. No abstract available.

49.

RNA mutagenesis and sporadic prion diseases.

Garcion E, Wallace B, Pelletier L, Wion D.

J Theor Biol. 2004 Sep 21;230(2):271-4.

PMID:
15302558
50.

Development of gliomas: potential role of asymmetrical cell division of neural stem cells.

Berger F, Gay E, Pelletier L, Tropel P, Wion D.

Lancet Oncol. 2004 Aug;5(8):511-4.

PMID:
15288241

Supplemental Content

Support Center